Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
AVEO Oncology (NASDAQ: AVEO) today reported first quarter 2013 financial results. In lieu of a quarterly financial update conference call, the AVEO management team expects to host a conference call on May 2, 2013 following the review by the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) of the company’s New Drug Application (NDA) for tivozanib.
Help employers find you! Check out all the jobs and post your resume.
